Schering’s product advocacy
Executive Summary
Schering-Plough names Mary-Frances Faraji as VP-global product communications & advocacy development to handle "non-advertising communications." In the newly created position, Faraji, formerly Pharmacia senior director of public relations and advocacy development, will report to another ex-Pharmacia employee, Schering Group VP-Global Communications Jeff Winton (1"The Pink Sheet" Sept. 15, 2003, p. 32)...
You may also be interested in...
Schering Drug Licensing Division To Be Headed By Ex-Pharmacia Exec
Ex-Pharmacia exec Michael DuBois will head Schering-Plough's newly formed product licensing division
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.